Article Sidebar

PDF
Date Published: 15/02/2023
Abstract Views: 199
Views PDF: 69
DOI: https://doi.org/10.51298/vmj.v521i2.4102
Issue
Vol. 521 No. 2 (2022)
Section
Các bài báo
How to Cite
Trần, C. B. ., Nguyễn, K. L. ., & Ngô , V. Đàn. (2023). STUDY ON 18FDG-PET/CT IMAGING CHARACTERISTICS OF LESIONS IN STOMACH CANCER BEFORE TREATMENT. Vietnam Medical Journal, 521(2). https://doi.org/10.51298/vmj.v521i2.4102

STUDY ON 18FDG-PET/CT IMAGING CHARACTERISTICS OF LESIONS IN STOMACH CANCER BEFORE TREATMENT

Công Bách Trần1,, Kim Lưu Nguyễn1, Văn Đàn Ngô 1
1 103 Military Hospital

Main Article Content

Abstract

Objective: Study on 18FDG-PET/CT imaging characteristics of lesions in stomach cancer before treatment. Methods: Retrospective study, descriptive analysis on 36 stomach cancer patients undergoing PET/CT before treatment at Military Hospital 103 from March 2021 to August 2022. Results: 36 patients with stomach cancer from March 2021 to August 2022. The mean tumor thickness was 16.5±7.69, the mean SUVmax of the tumor with a thickness of over 15mm was higher than that of a tumor with a thickness of less than 15mm, p<0.05. The average SUVmax tumor of bowel type was higher than that of diffuse type, p<0.05. There was no statistically significant difference in SUVmax value by stage T. After 8FDG PET/CT, stage N0 accounted for 47.22%, stage N1 accounted for 11.11%, stage N2 accounted for 13.89% , stage N3 accounted for 27.78%. There was no statistically significant difference in SUVmax by stage N. The highest SUVmax of metastatic lesions was 10.96±4.45 on average. The liver is the most common site of distant metastasis with the rate of 13.89%. There were 2 patients with distant metastases in 2 organs (5.56%). The mean SUVmax tumor value of patient group M1 was 14.97±8.12 higher than that of patient group M0 was 10.69±8.2, p>0.05.

Article Details

Keywords

PET/CT, Stomach cancer, Staging.

References

1. Sung H., Ferlay J., Siegel R.L, et al. (2021) “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”, CA Cancer J Clin., 71(3):209-249. .
2. Jiang M., Wang X., Shan X., et al. (2019) “Value of multi-slice spiral computed tomography in the diagnosis of metastatic lymph nodes and N-stage of gastric cancer”, Journal of International Medical Research., 47(1):281-292. .
3. Patricia M de Groot. et al. (2018). The epidemiology of lung cancer. Translational Lung Cancer Research, 7(3), 220.
4. Morgagni P., Petrella E., Basile B., et al. (2012) “Preoperative multidetector-row computed tomography scan staging for lymphatic gastric cancer spread”, World Journal of Surgical Oncology, 10(1):1-5.
5. Kim J.S. và Park S.Y. (2014). 18F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value. Asia Oceania Journal of Nuclear Medicine and Biology, 2(1), 12.
6. Bosch K.D., Chicklore S., Cook G.J. và cộng sự. (2020). Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment. European Journal of Nuclear Medicine and Molecular Imaging, 47(4), 759.
7. Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, et al. Expression of glucose transporter-1 in human gastric carcin-oma: association with tumor aggressiveness, metastasis, and patient survival. Cancer. 2001;92(3):634–41. .
8. Kim WS KY, Jang SJ, Kimm K, Jung MH. Glucose transporter 1 (GLUT1) expression is associated with intestinal type of gastric carcinoma. J Korean Med Sci. 2000;15:420–4. .
9. Yamada A, Oguchi K, Fukushima M, Imai Y, Kadoya M. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Ann Nucl Med. 2006;20(9):597–604. .
10. Nguyễn Văn Đàn (2022). Nghiên cứu đặc điểm hình ảnh của ung thư dạ dày và giá trị của cắt lớp vi tính 64 dãy trong đánh giá tổn thương các nhóm hạch vùng. Luận văn Bác sĩ nội trú. Học Viện Quân Y.